Galeneo Health Closes an Investment Round of 1 Million

Galeneo Health, a Spanish company specializing in the comprehensive management of offshore hospitalization services for patients has announced the closing of an investment round of one million euros led by Ship2B Ventures through the BSocial Impact Fund. In addition to the participation of other previous partners, the operation has had the collaboration of the European Investment Fund, Banco Sabadell, and Axis.

The company has assured that the funds will be aimed at consolidating the B2B model for clinics and hospitals and seeking to increase its participation within the public and pharmaceutical sectors. The firm has a digital platform that allows it to manage and monitor medical services and procedures developed in the patient’s homes.

Jaime García-Prieto, founder and executive director of Galeneo, has assured that “our mission is for a doctor to manage his patient from anywhere, guaranteeing continuity of care of at least the same quality that his patients have when they are admitted to his hospital. hospital plant”, according to the words of the company’s head.

Read more about Galeneo Health and find other important financial news with our companion app. The Born2Invest mobile app is available for free, for both Android and iOS devices, and keeps its readers up to date with the most important market updates.

Galeneo Health has a digital platform that allows you to manage and monitor medical services and procedures

The company has stated, in relation to the current demographic situation, that the uninterrupted aging of the population as the years progress will mean an increase in patients and their chronicity, which will entail greater socio-health spending. In fact, “if this situation is not reversed, the spending figure is expected to double worldwide by the year 2050 and exceed the Gross Domestic Product (GDP) of some developed countries,” as stated in the statement.

Jordi Ferrer, investment director of Ship2B Ventures, has stated that “ Galeneo is a pioneering decentralized hospitalization project in Spain, with a great social impact on three levels: patients can have a better recovery from their homes, greater conciliation is achieved of families by avoiding visiting the hospital, and the hospital system increases its capacity in a cost-efficient way without having to invest in more infrastructure,” as summarized by the manager.

Galeneo Health went on the market in 2021, and since then it has provided more than 18,000 services that have treated more than a thousand patients and families in twelve Spanish cities. The company has confirmed that all these services take place under qualified medical supervision, starring some of the main players in the national health sector. In total, it has more than 250 health professionals covering seven different disciplines.

__

(Featured image by Parentingupstream via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.